NFKB1 and B-cell chronic lymphocytic leukemia: In primary CLL B-cells, IL‐6 activated both STAT3 and NF‐κB, similar to the cascade described in hepatocytes (29), and we believe that this IL-6 mediated control mechanism can potentially control A2M production in CLL B-lymphocytes.